SE7408607L - - Google Patents

Info

Publication number
SE7408607L
SE7408607L SE7408607A SE7408607A SE7408607L SE 7408607 L SE7408607 L SE 7408607L SE 7408607 A SE7408607 A SE 7408607A SE 7408607 A SE7408607 A SE 7408607A SE 7408607 L SE7408607 L SE 7408607L
Authority
SE
Sweden
Application number
SE7408607A
Other versions
SE410264B (sv
Inventor
L Feuer
L Farkas
M Nogradi
B Vermes
A Gottsgen
A Wolfner
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7408607L publication Critical patent/SE7408607L/xx
Publication of SE410264B publication Critical patent/SE410264B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7408607A 1973-07-09 1974-06-28 Foder med viktstegrande tillsats i form av isoflavonderivat SE410264B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU37I1396A HU166380B (ru) 1973-07-09 1973-07-09

Publications (2)

Publication Number Publication Date
SE7408607L true SE7408607L (ru) 1975-01-10
SE410264B SE410264B (sv) 1979-10-08

Family

ID=10994486

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7408607A SE410264B (sv) 1973-07-09 1974-06-28 Foder med viktstegrande tillsats i form av isoflavonderivat
SE7711848A SE435509B (sv) 1973-07-09 1977-10-20 Sett att framstella 5-metyl-7-hydroxi-isoflavonderivat med anabolisk effekt

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7711848A SE435509B (sv) 1973-07-09 1977-10-20 Sett att framstella 5-metyl-7-hydroxi-isoflavonderivat med anabolisk effekt

Country Status (23)

Country Link
US (1) US4163746A (ru)
JP (1) JPS6028836B2 (ru)
AR (1) AR204996A1 (ru)
AT (1) AT340231B (ru)
BG (1) BG21859A3 (ru)
CA (1) CA1033750A (ru)
CH (1) CH614950A5 (ru)
CS (1) CS181861B1 (ru)
DD (2) DD122090A1 (ru)
DE (1) DE2432799C2 (ru)
DK (1) DK365374A (ru)
ES (1) ES427963A1 (ru)
FR (1) FR2236493B1 (ru)
GB (1) GB1434451A (ru)
HU (1) HU166380B (ru)
IL (1) IL45123A (ru)
NL (1) NL178875C (ru)
NO (1) NO138713C (ru)
PL (1) PL90015B1 (ru)
RO (1) RO70162A (ru)
SE (2) SE410264B (ru)
SU (1) SU682099A3 (ru)
YU (1) YU182474A (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
JPS6048924A (ja) * 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
US4644012A (en) * 1983-12-21 1987-02-17 Takeda Chemical Industries, Ltd. Treatment for osteoporosis
CH679584A5 (ru) * 1989-11-10 1992-03-13 Nestle Sa
US5278174A (en) * 1990-06-04 1994-01-11 Scios Nova, Inc. Sigma binding site agents
HUT68396A (en) * 1993-07-20 1995-04-25 Chinoin Gyogyszer Es Vegyeszet Method for preparing pharmaceutical preparation containing isoflavone derivative or salt of it
US5320949A (en) * 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
US6140469A (en) * 1993-10-12 2000-10-31 Protein Technologies International, Inc. Protein isolate having an increased level of isoflavone compounds and process for producing the same
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5827682A (en) * 1995-06-07 1998-10-27 Protein Technologies International, Inc. Two-step conversion of vegetable protein isoflavone conjugates to aglucones
US5851792A (en) * 1996-04-03 1998-12-22 Shen; Jerome Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey
US6015785A (en) * 1996-04-12 2000-01-18 Protein Technologies International, Inc. Aglucone isofavone enriched vegetable protein extract and isolate and process for producing
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
HUP0200117A2 (hu) * 1999-02-24 2002-05-29 Geza Bruckner Tápkeverékek és eljárások
AUPQ008299A0 (en) * 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
US6818668B2 (en) * 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
MXPA05000795A (es) * 2002-07-23 2005-04-19 Dsm Ip Assets Bv Manufactura de isoflavonas.
CN103030619B (zh) * 2008-05-28 2015-04-22 中国医学科学院药物研究所 5-甲基-7-甲氧异黄酮的晶c型、其制法和其药物组合物与用途
CN101591324B (zh) * 2008-05-28 2013-07-10 中国医学科学院药物研究所 5-甲基-7-甲氧异黄酮的三种晶型、其制法和其药物组合物与用途
AU2010303872B2 (en) 2009-10-09 2016-06-23 Société des Produits Nestlé S.A. Methods for preventing or treating sarcopenia and muscle atrophy in animals
WO2023147289A1 (en) * 2022-01-25 2023-08-03 The Regents Of The University Of Colorado, A Body Corporate Treatment of genitourinary syndrome of menopause

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE586723A (fr) * 1960-01-19 1960-07-19 Sarec S A Nouveaux composes chimiques et thérapeutiques dérives des isoflavones, et leurs procédés de préparation.
HU162377B (ru) * 1970-05-27 1973-02-28

Also Published As

Publication number Publication date
DE2432799A1 (de) 1975-01-30
SE7711848L (sv) 1977-10-20
SE435509B (sv) 1984-10-01
YU182474A (en) 1983-01-21
IL45123A (en) 1977-12-30
RO70162A (ro) 1982-07-06
IL45123A0 (en) 1974-09-10
NO138713C (no) 1978-11-01
CH614950A5 (en) 1979-12-28
BG21859A3 (bg) 1976-09-20
ES427963A1 (es) 1977-05-16
DE2432799C2 (de) 1986-01-02
NO138713B (no) 1978-07-24
CA1033750A (en) 1978-06-27
AT340231B (de) 1977-12-12
AR204996A1 (es) 1976-03-31
FR2236493B1 (ru) 1977-07-08
US4163746A (en) 1979-08-07
ATA523774A (de) 1977-03-15
JPS6028836B2 (ja) 1985-07-06
FR2236493A1 (ru) 1975-02-07
SE410264B (sv) 1979-10-08
NO742470L (ru) 1975-02-03
NL7408995A (nl) 1975-01-13
DD122090A1 (ru) 1976-09-12
DD115316A1 (ru) 1975-09-20
NL178875B (nl) 1986-01-02
DK365374A (ru) 1975-03-03
PL90015B1 (ru) 1976-12-31
GB1434451A (en) 1976-05-05
SU682099A3 (ru) 1979-08-25
HU166380B (ru) 1975-03-28
CS181861B1 (en) 1978-03-31
JPS5037781A (ru) 1975-04-08
NL178875C (nl) 1986-06-02

Similar Documents

Publication Publication Date Title
AR201758A1 (ru)
AU476761B2 (ru)
AU465372B2 (ru)
AR201235Q (ru)
AR201231Q (ru)
AU474593B2 (ru)
AU474511B2 (ru)
AU474838B2 (ru)
AU471343B2 (ru)
AU465453B2 (ru)
AU465434B2 (ru)
AU450229B2 (ru)
AU476714B2 (ru)
AR201229Q (ru)
AU466283B2 (ru)
AU476696B2 (ru)
AU472848B2 (ru)
AR199451A1 (ru)
AU477823B2 (ru)
AU461342B2 (ru)
AU471461B2 (ru)
AR200256A1 (ru)
AU476873B1 (ru)
AR210729A1 (ru)
AU477824B2 (ru)